Substance / Medication

Calcium polycarbophil

Overview

Active Ingredient
calcium polycarbophil
RxNorm CUI
20063

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Level 1a Evidence Comparing Use of Antibiotics Versus No Antibiotics in Management of Acute Left-Sided Uncomplicated Diverticulitis.
Sokhal Balamrit Singh, Mostafa Omar Ezzat Saber, Ramasamy Sadhasivam et al. · Am Surg · 2024
PMID: 38205505Meta-Analysis
Does surgery improve quality of life in patients with ongoing- or recurrent diverticulitis; a systematic review and meta-analysis.
Kertzman B A J, Amelung F J, Bolkenstein H E et al. · Scand J Gastroenterol · 2024
PMID: 38613245Meta-Analysis
Nonoperative management of acute complicated diverticulitis with pericolic and/or distant extraluminal air: A systematic review.
Morini Andrea, Zizzo Maurizio, Tumiati David et al. · World J Surg · 2024
PMID: 38844410Meta-Analysis
Effect of calcium polycarbophil on bowel function after restorative proctocolectomy for ulcerative colitis: a randomized controlled trial.
Shibata Chikashi, Funayama Yuji, Fukushima Kouhei et al. · Dig Dis Sci · 2007
PMID: 17394081RCT
Calcium polycarbophil improves constipation in non-traumatic spinal cord disorders.
Sakakibara Ryuji, Yamaguchi Taketo, Uchiyama Tomoyuki et al. · Clin Auton Res · 2006
PMID: 16810464Other
Calcium polycarbophil improves constipation in primary autonomic failure and multiple system atrophy subjects.
Sakakibara Ryuji, Yamaguchi Taketo, Uchiyama Tomoyuki et al. · Mov Disord · 2007
PMID: 17149723Trial
Lack of interaction between cefdinir and calcium polycarbophil: in vitro and in vivo studies.
Kato Ryuji, Ooi Kazuya, Takeda Kazuya et al. · Drug Metab Pharmacokinet · 2002
PMID: 15618687Trial
Impairment of ciprofloxacin absorption by calcium polycarbophil.
Kato Ryuji, Ueno Kazuyuki, Imano Hideki et al. · J Clin Pharmacol · 2002
PMID: 12092748Trial
Impairment of mycophenolate mofetil absorption by calcium polycarbophil.
Kato Ryuji, Ooi Kazuya, Ikura-Mori Megumi et al. · J Clin Pharmacol · 2002
PMID: 12412828Trial
Calcium polycarbophil, a water absorbing polymer, increases bowel movement and prevents sennoside-induced diarrhea in dogs.
Saito T, Yamada T, Iwanaga Y et al. · Jpn J Pharmacol · 2000
PMID: 10952069Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Calcium polycarbophil (substance)
SNOMED CT
412105005
UMLS CUI
C0054480
RxNorm CUI
20063

Clinical Data

This intervention maps to 7 entities in the Healos knowledge graph.

2
Conditions
2
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.